Pharmaceutical Technology-09-02-2011

Pharmaceutical Technology
Peer-Reviewed Research

September 02, 2011

The author prepared and analyzed a detailed design of experiments for the manufacture of a simple tablet formulation. The aim was to test whether tablet hardness and weight could be controlled during the compression process by adjusting certain machine parameters.

Pharmaceutical Technology
Industry Leaders

September 02, 2011

A Q&A with John Plachetka, chair, president, and CEO of POZEN, on recent industry trends.

Pharmaceutical Technology
Peer-Reviewed Research

September 02, 2011

A new, robust method for protein elution from ceramic hydroxyapatite.

Pharmaceutical Technology

PDUFA renewal legislation sets stage for new policies affecting revenue, resarch, and oversight.

Agent-in Place
Pharmaceutical Technology

September 02, 2011

Being aware of a forthcoming inspection or how a product was made can make a huge difference.

Pharmaceutical Technology
From The Editor

September 02, 2011

A report commissioned by FDA evaluates the QbD program.

Pharmaceutical Technology
PharmTech Talk

September 02, 2011

Internal and external Web-based communities are changing how pharma companies can innovate.

Pharmaceutical Technology

Directors from FDA's Center for Drug Evaluation and Research summarize findings in an FDA-commissioned report on QbD and propose actions the agency can take to encourage full-scale QbD implementation.

Pharmaceutical Technology
In the Field

September 02, 2011

Growth and change in Brazil and Mexico offer key opportunities for the region's pharmaceutical industry.

Pharmaceutical Technology
Outsourcing Outlook

September 02, 2011

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.

Online Exclusive
Pharmaceutical Technology

September 02, 2011

The author offers perspectives on ways in which pharmaceutical companies and other stakeholders in the supply chain can confront the threat of counterfeit products, cargo theft, illegal diversion, and economically motivated adulteration.

Pharmaceutical Technology
Packaging Forum

September 02, 2011

Smartphones could become the product-authentication tool of choice. Contains online bonus material.

Inside ICH
Pharmaceutical Technology

September 02, 2011

A summary of the latest steering committee and expert working groups' meeting.

Pharmaceutical Technology

Might European officials reverse their position on acceptable production methods?

BioForum
Pharmaceutical Technology

September 02, 2011

Reauthorization of pediatric exclusivity provisions looms in 2012 and debates begin anew.

International Federation of Pharmaceutical Manufacturers and Associations takes global action to improve public health.

Pharmaceutical Technology
Special Report

September 02, 2011

Industry buy-in is increasing as pharma companies proceed with select projects and research.

Pharmaceutical Technology
In the Spotlight

September 02, 2011

New product reviews for September 2011 focusing on manufacturing.

Pharma Ingredients
Pharmaceutical Technology

September 02, 2011

Researchers at MIT and Harvard University report on new methods for producing microscale hydrogels.

Pharmaceutical Technology
Viewpoint

September 02, 2011

After a series of structural changes, the author wonders whether USP is undergoing an identity crisis. USP CEO Roger L. Williams responds.

Pharmaceutical Technology

The third in a series of eight case studies from the Product Quality Research Institute focuses on facility biocontainment and inactivation.

Pharmaceutical Technology

Biocatalysis, chemocatalysis, and other chiral technologies continue to attract the investment dollars of CMOs and fine-chemical companies.

Pharmaceutical Technology

September 02, 2011

Click the title above to open the Pharmaceutical Technology September 2011 issue in an interactive PDF format.